1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page references 'Research board submission deadlines' as a linked resource but no specific dates are visible on the page itself.
The MRC Partnership Grant is a grant from the Medical Research Council (MRC) / UKRI that funds novel collaborative partnerships between diverse groups of researchers to establish new high-value activities or capabilities that add value to existing MRC and externally funded scientific programs.
Supported activities include specialist data and software platform development, training and career development in strategically important areas, multidisciplinary networking and consortium building, and shared infrastructure establishment. Grant amounts vary. Eligible applicants are diverse groupings of researchers; standalone hypothesis-driven research projects are not eligible.
Applications must include more than networking activities alone.
Get alerted about grants like this
Save a search for “MRC (Medical Research Council)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Partnership grant – MRC – UKRI The Medical Research Council (MRC) partnership grant funding opportunity is designed to support novel partnerships between diverse groupings of researchers. Funding will be provided to establish new, high-value collaborative activities or capabilities that should add value to high-quality scientific programmes that are already supported by grants from MRC and other funders.
It is not designed to fund standalone, hypothesis-driven research projects, which may otherwise be eligible for MRC research type funding. Examples of collaborative activities Collaborative activities can include: Platform activities such as specialist data and software platforms or resources Training, career development and capacity building in strategically important areas They could also include the following activities.
Networking and partnership activities establishing multidisciplinary collaborative partnerships or consortia fostering or enabling a national or international strategy across the field enabling knowledge sharing or creation across institutions Infrastructure support for establishing a unique shared resource or helping to exploit it For example, this could be staff, systems, equipment, seminars, workshops.
This could include a coordinated set of needs-led and complementary networking activities, including outreach work and travel, with a defined output. Funds to support small scale, pump-priming projects may be considered However, specific research questions should not be the focus of the partnership.
These projects should be interdisciplinary, high risk or gain projects which will demonstrate the novel capability of a new partnership Examples of successful grants Typically, successful partnership grants include a combination of these components. Applications for funding to support only networking activities will be rejected. Refer to the partnership grant case studies as exemplars of successful grants.
Partnership grants are expected to reach maturity by the end of the initial award, with any follow-on activities supported through alternative mechanisms. Last updated: 13 February 2026 This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .
According to the current listing, eligibility includes: Open to diverse groupings of researchers; supports collaborative activities or capabilities including platform development, training initiatives, and networking activities rather than standalone research projects. Confirm the full requirements in the official notice before applying.
Partnership grant – MRC is funded by MRC (Medical Research Council). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Supports clinical trials that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes, focusing on fundamental aspects of phenomena without specific application towards processes or products in mind.
DARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleThe BARK program funds dual-use medical products for warfighters and military working dogs — tourniquets, sensors, drug delivery, and CBRN countermeasures. Proposals close June 3, 2026.
Read article